-
Corticosteroid use is associated with an increased risk of symptomatic pulmonary embolism. The greatest risk is in the first 30 days of use and increases with increasing steroid dose.
-
This study reports an association between infection burden and dementia, although the relationship may not be causal.
-
Beta-blockers and noncardiac surgery; prenatal medication exposure and risk of autism; reasons for statin discontinuations; and FDA actions.
-
Colchicine, in addition to statins and other standard secondary prevention therapies, appeared effective for the prevention of cardiovascular events in patients with stable coronary disease.
-
As a federal program rolls out to award providers with incentives for achieving meaningful use in electronic health records, wide measure-by-measure variation can jeopardize the validity of electronic reporting.
-
On January 14, 2013, the FDA approved a device allowing detection of multiple gastrointestinal pathogens from a single sample of feces.1
-
The Internet age has brought all kinds of conveniences and apps for your smart phone, from the popular app GRINDR (allowing you a speedy hookup with the nearest sexually available individual) to the newest MedXSafe, which allows you to literally bump phones and share confidential STD and HIV info before you bump into bed.
-
The ECG shown above was obtained from a 62-year-old man who presented to the emergency department with a history of several presyncopal episodes in recent months. His ECG was diagnosed as showing acute anterior ST elevation myocardial infarction (STEMI). Do you agree? What treatment is indicated?
-
Calcium supplementation in women; type 2 diabetes treatments and pancreatitis risk; treating chronic idiopathic urticaria; rivaroxaban and VTE; and FDA actions.
-
An oral multikinase inhibitor has been approved by the FDA for treatment of metastatic colorectal cancer as well as advanced gastrointestinal stromal tumors (GIST). Regorafenib is marketed by Bayer HealthCare Pharmaceuticals as Stivarga.
